Genetic Technologies Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018 - 2003
Net Income	-11.75	-7.13	-7.08	-6.29	-6.43	Upgrade
Other Operating Activities	2.03	1.47	0.78	0.58	0.35	Upgrade
Operating Cash Flow	-9.72	-5.66	-6.3	-5.71	-6.07	Upgrade
Capital Expenditures	-0.02	-0.06	-0.75	-0	-0.05	Upgrade
Acquisitions	-0.49	-3.4	0	0	-0.5	Upgrade
Change in Investments	0	0	0	0.04	0	Upgrade
Other Investing Activities	0.19	0	-	0.02	0.03	Upgrade
Investing Cash Flow	-0.31	-3.46	-0.75	0.06	-0.52	Upgrade
Share Issuance / Repurchase	7.17	0	15.9	21.79	3.56	Upgrade
Debt Issued / Paid	-0.34	-0.27	-0.24	-0.13	0	Upgrade
Other Financing Activities	-0.92	-0.01	-1.97	-3.3	-0.43	Upgrade
Financing Cash Flow	5.92	-0.28	13.69	18.36	3.13	Upgrade
Exchange Rate Effect	0.23	0.23	0.04	-0.63	0.12	Upgrade
Net Cash Flow	-4.12	-9.4	6.65	12.71	-3.47	Upgrade
Free Cash Flow	-9.74	-5.72	-7.04	-5.71	-6.12	Upgrade
Free Cash Flow Margin	-112.14%	-84.23%	-5843.55%	-57919.69%	-24066.54%	Upgrade
Free Cash Flow Per Share	-57.65	-37.24	-49.47	-82.50	-139.41	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).